Adam Raymond Craig's most recent trade in X4 Pharmaceuticals Inc was a trade of 2,329,154 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| X4 Pharma Inc | Adam Raymond Craig | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2025 | 2,329,154 | 2,329,154 | - | - | Stock Option (right to buy) | |
| X4 Pharma Inc | Adam Raymond Craig | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 23 Oct 2025 | 86,206 | 376,087 (2%) | 0% | 2.9 | 249,997 | Common Stock |
| X4 Pharma Inc | Adam Raymond Craig | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 1,609,873 | 1,609,873 | - | - | Stock Option (right to buy) | |
| X4 Pharma Inc | Adam Raymond Craig | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 529,201 | 529,201 | - | - | Stock Option (right to buy) | |
| X4 Pharma Inc | Adam Raymond Craig | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 289,881 | 289,881 (1%) | 1% | 0 | Common Stock |